我oinn所有的现金在股市

哈哈哈哈啊！

亏钱也就那样

收股息等机会哈哈哈哈啊

142K
本金投资股市
目前亏了23K

只要不再新低
单靠股息
明年起
1年拿5300
4年也可以回血
而且4年后应该是股价也不亏了
全部买好公司
没理由4年后还巨亏
GENM 2.52
GENTING 4.05
SHANG 2.2
CDB 3.63

明天genm
genting将要出业绩啦
希望不是业绩炸弹

少赚点没事

只要业绩维持青青就好了

业绩肯定没很好
只要不红红

有中原一点青就满足了
哈哈哈哈啊

星期一那天，美国一家开发阿尔兹海默症药物的上市公司- SAVA， 因其研究中的药物临床试验失败，一夜之间股价暴跌-83.78% ，这彰显出药物研究的投资风险十分巨大。 云顶集团在美国投资一家叫 TauRX 的医药公司，持股20%股份，也是研究治疗阿尔兹海默症的药物，若投资云顶想着靠这题材实现云顶股价暴涨，失败风险相对蛮高的。要慎重

In 2024, Genting's Miami waterfront site has attracted multiple bids, with some exceeding $1 billion. Potential buyers include major developers aiming to utilize the 15.5-acre site for mixed-use projects like residential, office, and entertainment spaces. The highest bid reportedly values the property at $1.5 billion

Genting's 15.5-acre waterfront site in Miami is considered a prime location. It is situated in the Omni District, offering approximately 800 feet of Biscayne Bay frontage. The property benefits from highly favorable zoning, including unlimited buildable square footage, no setbacks, and the ability to build structures up to 649 feet tall. This zoning flexibility, combined with its central location near downtown Miami, makes it one of the most desirable development opportunities in the U.S. Additionally, Miami's rapid growth and influx of high-income earners and businesses further enhance its appeal​